Click here to receive MS news via e-mail
There is a lower than expected number of cancer cases in multiple sclerosis (MS) patients compared to the general population, according to a recent study. In addition, MS patients with a personal history of cancer were more likely to report disease modifying therapies (DMT) use suggesting that DMTs may abrogate the lower incidence of cancer in MS. Cancer, DMT use, and family history of cancer were assessed using the New York State Multiple Sclerosis Consortium (NYSMSC) registry. Self-reported cancers in MS patients were tested for associations with DMT use, family history of cancer, and other factors. Researchers found:
MS Views and News
Providing educational information, resources and services for those affected by MS
MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis
